PYPD Latest Press Releases

-- April 13, 2026 --

PolyPid to Present New Phase 3 SHIELD II Data Demonstrating D-PLEX100 Sustained Local Release at ESCMID Global 2026 Globe Newswire 9:15 AM

-- March 31, 2026 --

PolyPid Initiates D-PLEX100 NDA Submission to the FDA Globe Newswire 8:30 AM

-- March 17, 2026 --

PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX100's New Drug Application Globe Newswire 8:30 AM

-- February 25, 2026 --

PolyPid Announces Participation in Upcoming Investor Conferences Globe Newswire 8:35 AM

-- February 11, 2026 --

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results Globe Newswire 7:30 AM

-- January 28, 2026 --

PolyPid to Report Fourth Quarter 2025 Financial Results and Operational Highlights on February 11, 2026 Globe Newswire 8:00 AM

-- December 16, 2025 --

PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors Globe Newswire 8:30 AM

-- December 3, 2025 --

PolyPid Announces Positive FDA Pre-NDA Meeting Minutes for D-PLEX100 Supporting NDA Submission Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software